1 Antivirals Market Overview 1.1 Product Overview and Scope of Antivirals 1.2 Antivirals Segment by Type 1.2.1 Global Antivirals Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Generic 1.2.3 Branded 1.3 Antivirals Segment by Application 1.3.1 Global Antivirals Sales Comparison by Application: (2021-2027) 1.3.2 HIV 1.3.3 Hepatitis 1.3.4 HSV 1.3.5 Influenza 1.4 Global Antivirals Market Size Estimates and Forecasts 1.4.1 Global Antivirals Revenue 2016-2027 1.4.2 Global Antivirals Sales 2016-2027 1.4.3 Antivirals Market Size by Region: 2016 Versus 2021 Versus 2027 2 Antivirals Market Competition by Manufacturers 2.1 Global Antivirals Sales Market Share by Manufacturers (2016-2021) 2.2 Global Antivirals Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Antivirals Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Antivirals Manufacturing Sites, Area Served, Product Type 2.5 Antivirals Market Competitive Situation and Trends 2.5.1 Antivirals Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Antivirals Players Market Share by Revenue 2.5.3 Global Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Antivirals Retrospective Market Scenario by Region 3.1 Global Antivirals Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Antivirals Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Antivirals Market Facts & Figures by Country 3.3.1 North America Antivirals Sales by Country 3.3.2 North America Antivirals Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Antivirals Market Facts & Figures by Country 3.4.1 Europe Antivirals Sales by Country 3.4.2 Europe Antivirals Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Antivirals Market Facts & Figures by Region 3.5.1 Asia Pacific Antivirals Sales by Region 3.5.2 Asia Pacific Antivirals Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Antivirals Market Facts & Figures by Country 3.6.1 Latin America Antivirals Sales by Country 3.6.2 Latin America Antivirals Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Antivirals Market Facts & Figures by Country 3.7.1 Middle East and Africa Antivirals Sales by Country 3.7.2 Middle East and Africa Antivirals Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Antivirals Historic Market Analysis by Type 4.1 Global Antivirals Sales Market Share by Type (2016-2021) 4.2 Global Antivirals Revenue Market Share by Type (2016-2021) 4.3 Global Antivirals Price by Type (2016-2021) 5 Global Antivirals Historic Market Analysis by Application 5.1 Global Antivirals Sales Market Share by Application (2016-2021) 5.2 Global Antivirals Revenue Market Share by Application (2016-2021) 5.3 Global Antivirals Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck 6.1.1 Merck Corporation Information 6.1.2 Merck Description and Business Overview 6.1.3 Merck Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck Antivirals Product Portfolio 6.1.5 Merck Recent Developments/Updates 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Corporation Information 6.2.2 Johnson & Johnson Description and Business Overview 6.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Johnson & Johnson Antivirals Product Portfolio 6.2.5 Johnson & Johnson Recent Developments/Updates 6.3 Teva Pharmaceutical Industries 6.3.1 Teva Pharmaceutical Industries Corporation Information 6.3.2 Teva Pharmaceutical Industries Description and Business Overview 6.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Teva Pharmaceutical Industries Antivirals Product Portfolio 6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates 6.4 GSK 6.4.1 GSK Corporation Information 6.4.2 GSK Description and Business Overview 6.4.3 GSK Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.4.4 GSK Antivirals Product Portfolio 6.4.5 GSK Recent Developments/Updates 6.5 Mylan 6.5.1 Mylan Corporation Information 6.5.2 Mylan Description and Business Overview 6.5.3 Mylan Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Mylan Antivirals Product Portfolio 6.5.5 Mylan Recent Developments/Updates 6.6 Gilead Sciences 6.6.1 Gilead Sciences Corporation Information 6.6.2 Gilead Sciences Description and Business Overview 6.6.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Gilead Sciences Antivirals Product Portfolio 6.6.5 Gilead Sciences Recent Developments/Updates 6.7 F. Hoffmann-La Roche 6.6.1 F. Hoffmann-La Roche Corporation Information 6.6.2 F. Hoffmann-La Roche Description and Business Overview 6.6.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.4.4 F. Hoffmann-La Roche Antivirals Product Portfolio 6.7.5 F. Hoffmann-La Roche Recent Developments/Updates 6.8 Bristol-Myers-Squibb 6.8.1 Bristol-Myers-Squibb Corporation Information 6.8.2 Bristol-Myers-Squibb Description and Business Overview 6.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Bristol-Myers-Squibb Antivirals Product Portfolio 6.8.5 Bristol-Myers-Squibb Recent Developments/Updates 6.9 AbbVie 6.9.1 AbbVie Corporation Information 6.9.2 AbbVie Description and Business Overview 6.9.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.9.4 AbbVie Antivirals Product Portfolio 6.9.5 AbbVie Recent Developments/Updates 6.10 Aurobindo Pharma 6.10.1 Aurobindo Pharma Corporation Information 6.10.2 Aurobindo Pharma Description and Business Overview 6.10.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Aurobindo Pharma Antivirals Product Portfolio 6.10.5 Aurobindo Pharma Recent Developments/Updates 6.11 Cipla 6.11.1 Cipla Corporation Information 6.11.2 Cipla Antivirals Description and Business Overview 6.11.3 Cipla Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Cipla Antivirals Product Portfolio 6.11.5 Cipla Recent Developments/Updates 6.12 Dr Reddy’s 6.12.1 Dr Reddy’s Corporation Information 6.12.2 Dr Reddy’s Antivirals Description and Business Overview 6.12.3 Dr Reddy’s Antivirals Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Dr Reddy’s Antivirals Product Portfolio 6.12.5 Dr Reddy’s Recent Developments/Updates 7 Antivirals Manufacturing Cost Analysis 7.1 Antivirals Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Antivirals 7.4 Antivirals Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Antivirals Distributors List 8.3 Antivirals Customers 9 Antivirals Market Dynamics 9.1 Antivirals Industry Trends 9.2 Antivirals Growth Drivers 9.3 Antivirals Market Challenges 9.4 Antivirals Market Restraints 10 Global Market Forecast 10.1 Antivirals Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Antivirals by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Antivirals by Type (2022-2027) 10.2 Antivirals Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Antivirals by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Antivirals by Application (2022-2027) 10.3 Antivirals Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Antivirals by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Antivirals by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Antivirals Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Antivirals Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Antivirals Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Antivirals Covered in This Study Table 5. Global Antivirals Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Antivirals Sales Market Share by Manufacturers (2016-2021) Table 7. Global Antivirals Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Antivirals Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Antivirals Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Antivirals Manufacturing Sites and Area Served Table 11. Manufacturers Antivirals Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Antivirals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivirals as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Antivirals Sales by Region (2016-2021) & (K MT) Table 16. Global Antivirals Sales Market Share by Region (2016-2021) Table 17. Global Antivirals Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Antivirals Sales by Country (2016-2021) & (K MT) Table 19. North America Antivirals Sales Market Share by Country (2016-2021) Table 20. North America Antivirals Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Antivirals Revenue Market Share by Country (2016-2021) Table 22. Europe Antivirals Sales by Country (2016-2021) & (K MT) Table 23. Europe Antivirals Sales Market Share by Country (2016-2021) Table 24. Europe Antivirals Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Antivirals Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Antivirals Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Antivirals Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Antivirals Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Antivirals Revenue Market Share by Region (2016-2021) Table 30. Latin America Antivirals Sales by Country (2016-2021) & (K MT) Table 31. Latin America Antivirals Sales Market Share by Country (2016-2021) Table 32. Latin America Antivirals Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Antivirals Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Antivirals Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Antivirals Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Antivirals Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Antivirals Revenue Market Share by Country (2016-2021) Table 38. Global Antivirals Sales (K MT) by Type (2016-2021) Table 39. Global Antivirals Sales Market Share by Type (2016-2021) Table 40. Global Antivirals Revenue (Million US$) by Type (2016-2021) Table 41. Global Antivirals Revenue Share by Type (2016-2021) Table 42. Global Antivirals Price (USD/Unit) by Type (2016-2021) Table 43. Global Antivirals Sales (K MT) by Application (2016-2021) Table 44. Global Antivirals Sales Market Share by Application (2016-2021) Table 45. Global Antivirals Revenue (Million US$) by Application (2016-2021) Table 46. Global Antivirals Revenue Share by Application (2016-2021) Table 47. Global Antivirals Price (USD/Unit) by Application (2016-2021) Table 48. Merck Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck Antivirals Product Table 52. Merck Recent Developments/Updates Table 53. Johnson & Johnson Corporation Information Table 54. Johnson & Johnson Description and Business Overview Table 55. Johnson & Johnson Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Johnson & Johnson Antivirals Product Table 57. Johnson & Johnson Recent Developments/Updates Table 58. Teva Pharmaceutical Industries Corporation Information Table 59. Teva Pharmaceutical Industries Description and Business Overview Table 60. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Teva Pharmaceutical Industries Antivirals Product Table 62. Teva Pharmaceutical Industries Recent Developments/Updates Table 63. GSK Corporation Information Table 64. GSK Description and Business Overview Table 65. GSK Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. GSK Antivirals Product Table 67. GSK Recent Developments/Updates Table 68. Mylan Corporation Information Table 69. Mylan Description and Business Overview Table 70. Mylan Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Mylan Antivirals Product Table 72. Mylan Recent Developments/Updates Table 73. Gilead Sciences Corporation Information Table 74. Gilead Sciences Description and Business Overview Table 75. Gilead Sciences Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Gilead Sciences Antivirals Product Table 77. Gilead Sciences Recent Developments/Updates Table 78. F. Hoffmann-La Roche Corporation Information Table 79. F. Hoffmann-La Roche Description and Business Overview Table 80. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. F. Hoffmann-La Roche Antivirals Product Table 82. F. Hoffmann-La Roche Recent Developments/Updates Table 83. Bristol-Myers-Squibb Corporation Information Table 84. Bristol-Myers-Squibb Description and Business Overview Table 85. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Bristol-Myers-Squibb Antivirals Product Table 87. Bristol-Myers-Squibb Recent Developments/Updates Table 88. AbbVie Corporation Information Table 89. AbbVie Description and Business Overview Table 90. AbbVie Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. AbbVie Antivirals Product Table 92. AbbVie Recent Developments/Updates Table 93. Aurobindo Pharma Corporation Information Table 94. Aurobindo Pharma Description and Business Overview Table 95. Aurobindo Pharma Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Aurobindo Pharma Antivirals Product Table 97. Aurobindo Pharma Recent Developments/Updates Table 98. Cipla Corporation Information Table 99. Cipla Description and Business Overview Table 100. Cipla Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Cipla Antivirals Product Table 102. Cipla Recent Developments/Updates Table 103. Dr Reddy’s Corporation Information Table 104. Dr Reddy’s Description and Business Overview Table 105. Dr Reddy’s Antivirals Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Dr Reddy’s Antivirals Product Table 107. Dr Reddy’s Recent Developments/Updates Table 108. Production Base and Market Concentration Rate of Raw Material Table 109. Key Suppliers of Raw Materials Table 110. Antivirals Distributors List Table 111. Antivirals Customers List Table 112. Antivirals Market Trends Table 113. Antivirals Growth Drivers Table 114. Antivirals Market Challenges Table 115. Antivirals Market Restraints Table 116. Global Antivirals Sales Forecast by Type (2022-2027) & (K MT) Table 117. Global Antivirals Sales Market Share Forecast by Type (2022-2027) Table 118. Global Antivirals Revenue Forecast by Type (2022-2027) & (US$ Million) Table 119. Global Antivirals Revenue Market Share Forecast by Type (2022-2027) Table 120. Global Antivirals Sales Forecast by Application (2022-2027) & (K MT) Table 121. Global Antivirals Sales Market Share Forecast by Application (2022-2027) Table 122. Global Antivirals Revenue Forecast by Application (2022-2027) & (US$ Million) Table 123. Global Antivirals Revenue Market Share Forecast by Application (2022-2027) Table 124. Global Antivirals Sales Forecast by Region (2022-2027) & (K MT) Table 125. Global Antivirals Sales Market Share Forecast by Region (2022-2027) Table 126. Global Antivirals Revenue Forecast by Region (2022-2027) & (US$ Million) Table 127. Global Antivirals Revenue Market Share Forecast by Region (2022-2027) Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Antivirals Figure 2. Global Antivirals Market Share by Type in 2020 & 2027 Figure 3. Generic Product Picture Figure 4. Branded Product Picture Figure 5. Global Antivirals Market Share by Application in 2020 & 2027 Figure 6. HIV Figure 7. Hepatitis Figure 8. HSV Figure 9. Influenza Figure 10. Global Antivirals Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Antivirals Market Size 2016-2027 (US$ Million) Figure 12. Global Antivirals Sales 2016-2027 (K MT) Figure 13. Global Antivirals Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Antivirals Sales Share by Manufacturers in 2020 Figure 15. Global Antivirals Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Antivirals Players: Market Share by Revenue in 2020 Figure 17. Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Antivirals Sales Market Share by Region (2016-2021) Figure 19. Global Antivirals Sales Market Share by Region in 2020 Figure 20. Global Antivirals Revenue Market Share by Region (2016-2021) Figure 21. Global Antivirals Revenue Market Share by Region in 2020 Figure 22. U.S. Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Antivirals Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Antivirals by Type (2016-2021) Figure 47. Sales Market Share of Antivirals by Application (2016-2021) Figure 48. Sales Market Share of Antivirals by Application in 2020 Figure 49. Revenue Share of Antivirals by Application (2016-2021) Figure 50. Revenue Share of Antivirals by Application in 2020 Figure 51. Manufacturing Cost Structure of Antivirals Figure 52. Manufacturing Process Analysis of Antivirals Figure 53. Antivirals Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Merck Johnson & Johnson Teva Pharmaceutical Industries GSK Mylan Gilead Sciences F. Hoffmann-La Roche Bristol-Myers-Squibb AbbVie Aurobindo Pharma Cipla Dr Reddy’s